BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,957,146 | -19.4% | 51,622 | -2.8% | 0.04% | -20.5% |
| Q2 2023 | $2,427,791 | +30.0% | 53,130 | +15.9% | 0.04% | +25.7% |
| Q1 2023 | $1,867,049 | -32.6% | 45,827 | -15.5% | 0.04% | -38.6% |
| Q4 2022 | $2,769,595 | -12.3% | 54,219 | -7.5% | 0.06% | -18.6% |
| Q3 2022 | $3,157,000 | +105.9% | 58,617 | +145.6% | 0.07% | +118.8% |
| Q2 2022 | $1,533,000 | -46.0% | 23,864 | -34.8% | 0.03% | -36.0% |
| Q1 2022 | $2,840,000 | -0.8% | 36,621 | +9.8% | 0.05% | -2.0% |
| Q4 2021 | $2,864,000 | +76.7% | 33,363 | +65.5% | 0.05% | +75.9% |
| Q3 2021 | $1,621,000 | +39.7% | 20,154 | +39.9% | 0.03% | +31.8% |
| Q2 2021 | $1,160,000 | -29.7% | 14,405 | -26.4% | 0.02% | -40.5% |
| Q1 2021 | $1,650,000 | +102.5% | 19,566 | +94.9% | 0.04% | -41.3% |
| Q1 2020 | $815,000 | -43.5% | 10,038 | -41.8% | 0.06% | +61.5% |
| Q4 2019 | $1,443,000 | +36.3% | 17,257 | +42.5% | 0.04% | +2.6% |
| Q3 2019 | $1,059,000 | -7.8% | 12,109 | -8.4% | 0.04% | -11.6% |
| Q2 2019 | $1,149,000 | +1.3% | 13,214 | -8.0% | 0.04% | -10.4% |
| Q1 2019 | $1,134,000 | -11.8% | 14,368 | -26.4% | 0.05% | -15.8% |
| Q4 2018 | $1,285,000 | -1.2% | 19,521 | +15.8% | 0.06% | +11.8% |
| Q3 2018 | $1,300,000 | +45.9% | 16,860 | +39.8% | 0.05% | +30.8% |
| Q2 2018 | $891,000 | +33.6% | 12,062 | +17.7% | 0.04% | +21.9% |
| Q1 2018 | $667,000 | -1.2% | 10,250 | -1.9% | 0.03% | -5.9% |
| Q4 2017 | $675,000 | -15.6% | 10,444 | -18.0% | 0.03% | -22.7% |
| Q3 2017 | $800,000 | -1.6% | 12,741 | -5.1% | 0.04% | -12.0% |
| Q2 2017 | $813,000 | +52.2% | 13,427 | +30.4% | 0.05% | +42.9% |
| Q1 2017 | $534,000 | +34.8% | 10,300 | +15.4% | 0.04% | +16.7% |
| Q4 2016 | $396,000 | -69.3% | 8,927 | -67.1% | 0.03% | -74.8% |
| Q3 2016 | $1,290,000 | +40.8% | 27,099 | +36.7% | 0.12% | +20.2% |
| Q2 2016 | $916,000 | +52.7% | 19,822 | +35.6% | 0.10% | +45.6% |
| Q1 2016 | $600,000 | +50.8% | 14,614 | +156.8% | 0.07% | +44.7% |
| Q2 2015 | $398,000 | -44.3% | 5,691 | -45.5% | 0.05% | -42.0% |
| Q1 2015 | $715,000 | -20.6% | 10,439 | -15.1% | 0.08% | -15.6% |
| Q4 2014 | $901,000 | +26.2% | 12,290 | +23.5% | 0.10% | +31.5% |
| Q3 2014 | $714,000 | -17.8% | 9,951 | -17.2% | 0.07% | -16.1% |
| Q2 2014 | $869,000 | -0.8% | 12,014 | +1.0% | 0.09% | -2.2% |
| Q1 2014 | $876,000 | -1.0% | 11,900 | -6.5% | 0.09% | +1.1% |
| Q4 2013 | $885,000 | -3.6% | 12,731 | -8.9% | 0.09% | -7.4% |
| Q3 2013 | $918,000 | +3.6% | 13,982 | +9.3% | 0.10% | -12.0% |
| Q2 2013 | $886,000 | – | 12,790 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |